Entecavir

Janessa Smith, Pharm.D. BCPS, Paul A. Pham, Pharm.D.
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID

INDICATIONS

FDA

  • Treatment of chronic hepatitis B (HBV) infection in adults and children at least 2 years of age with evidence of active disease (active viral replication, elevated ALT or AST or histologic evidence of active disease).

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 2, 2017